adopted a similar strategy of co‐delivering IL‐15‐loaded nanoparticles and melanoma‐specific CAR‐T cells in a post‐resection melanoma model in mice.[58] Post‐resection recurrence of melanoma is a common complication, and as many as 50% of the patients demonstrate recurrence of the malignancy. The gene discussed is IL15; the disease is melanoma.